Court Rules Against Johnson & Johnson in Patent Suit

Features Reuters

Boston Scientific Corp said on Monday the U.S. District Court for the District of New Jersey ruled in its favor, finding all patents in a suit brought by Johnson & Johnson to be invalid.

Continue Reading Below

Johnson & Johnson in the 2008 suit alleged that Boston Scientific's Promus Everolimus-Eluting Coronary Stent System infringed two patents, known as the Morris patents, relating to the use of the drug on the stent.